Ibrance 100 MG tablet 7S
Ended Awarded Last action
- Contract number
- SPE2DR26F9EP0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,120
Award facts
- Contract value 100% obligated
- $17,119.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $17,119.68 by the Defense Logistics Agency (DLA) on December 5, 2025, for the supply of Ibrance 100 mg tablets. The contract operates under firm fixed pricing with an ultimate completion date of December 29, 2025, and was competitively awarded without a set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The DLA Medical Supply Chain utilizes this indefinite delivery vehicle to procure critical medications for Defense Health Agency customers, the U.S. Coast Guard, and other federal healthcare systems. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability in delivering diverse pharmaceutical commodities, including specialty medications and brand-name drugs, through open competition. The company's position as one of multiple potential contractors under the DLA's planned Pharmaceutical Prime Vendor Global Program Generation V initiative underscores its role as a significant vendor within the federal medical procurement landscape.
Quick answers
Who was awarded contract SPE2DR26F9EP0?
SPE2DR26F9EP0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F9EP0 worth?
The government has obligated $17,120 on SPE2DR26F9EP0.
Is contract SPE2DR26F9EP0 an order under another contract?
Yes. SPE2DR26F9EP0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9EP0 competed?
The extent of competition for SPE2DR26F9EP0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award